Literature DB >> 14662953

Molecular epidemiology of penicillin-susceptible non-beta-lactam-resistant Streptococcus pneumoniae isolates from Greek children.

D Bogaert1, P W M Hermans, I N Grivea, G S Katopodis, T J Mitchell, M Sluijter, R De Groot, N G Beratis, G A Syrogiannopoulos.   

Abstract

A total of 128 Streptococcus pneumoniae isolates that were susceptible to penicillin but resistant to non-beta-lactam agents were isolated from young carriers in Greece and analyzed by antibiotic susceptibility testing, serotyping, restriction fragment end labeling (RFEL), and antibiotic resistance genotyping. The serotypes 6A/B (49%), 14 (14%), 19A/F (11%), 11A (9%), 23A/F (4%), 15B/C (2%), and 21 (2%) were most prevalent in this collection. Of the isolates, 65% were erythromycin resistant, while the remaining isolates were tetracycline and/or trimethoprim-sulfamethoxazole resistant. Fifty-nine distinct RFEL types were identified. Twenty different RFEL clusters, harboring 2 to 19 strains each, accounted for 76% of all strains. Confirmatory multilocus sequence typing analysis of the genetic clusters showed the presence of three international clones (Tennessee(23F)-4, England(14)-9, and Greece(6B)-22) representing 30% of the isolates. The erm(B) gene was present in 70% of the erythromycin-resistant isolates, whereas 18 and 8% contained the mef(A) and mef(E) genes, respectively. The pneumococci representing erm(B), erm(A), and mef genes belonged to distinct genetic clusters. In total, 45% of all isolates were tetracycline resistant. Ninety-six percent of these isolates contained the tet(M) gene. In conclusion, penicillin-susceptible pneumococci resistant to non-beta-lactams are a genetically heterogeneous group displaying a variety of genotypes, resistance markers, and serotypes. This suggests that multiple genetic events lead to non-beta-lactam-resistant pneumococci in Greece. Importantly, most of these genotypes are capable of disseminating within the community.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662953      PMCID: PMC308965          DOI: 10.1128/JCM.41.12.5633-5639.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Antimicrobial use and serotype distribution of nasopharyngeal Streptococcus pneumoniae isolates recovered from Greek children younger than 2 years old.

Authors:  George A Syrogiannopoulos; George D Katopodis; Ioanna N Grivea; Nicholas G Beratis
Journal:  Clin Infect Dis       Date:  2002-10-21       Impact factor: 9.079

2.  Molecular epidemiology of drug-resistant pneumococci: toward an international approach.

Authors:  P W Hermans; M Sluijter; S Dejsirilert; N Lemmens; K Elzenaar; A van Veen; W H Goessens; R de Groot
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

3.  Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae.

Authors:  M Del Grosso; F Iannelli; C Messina; M Santagati; N Petrosillo; S Stefani; G Pozzi; A Pantosti
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Genomic DNA fingerprinting by restriction fragment end labeling.

Authors:  T J van Steenbergen; S D Colloms; P W Hermans; J de Graaff; R H Plasterk
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

5.  Multidrug-resistant Streptococcus pneumoniae in Poland: identification of emerging clones.

Authors:  K Overweg; P W Hermans; K Trzcinski; M Sluijter; R de Groot; W Hryniewicz
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

Review 7.  Will resistance to ketolides develop in Streptococcus pneumoniae?

Authors:  R Leclercq
Journal:  J Infect       Date:  2002-02       Impact factor: 6.072

8.  Molecular characterization of pneumococcal nasopharynx isolates collected from children during their first 2 years of life.

Authors:  M Sluijter; H Faden; R de Groot; N Lemmens; W H Goessens; A van Belkum; P W Hermans
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

9.  A novel multiresistant Streptococcus pneumoniae serogroup 19 clone from Washington State identified by pulsed-field gel electrophoresis and restriction fragment length patterns.

Authors:  V A Luna; D B Jernigan; A Tice; J D Kellner; M C Roberts
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

10.  Automated pneumococcal MLST using liquid-handling robotics and a capillary DNA sequencer.

Authors:  Johanna Jefferies; Stuart C Clarke; Mathew A Diggle; Andrew Smith; Chris Dowson; Tim Mitchell
Journal:  Mol Biotechnol       Date:  2003-07       Impact factor: 2.860

View more
  4 in total

1.  Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance.

Authors:  S Nunes; R Sá-Leão; J Carriço; C R Alves; R Mato; A Brito Avô; J Saldanha; J S Almeida; I Santos Sanches; H de Lencastre
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002.

Authors:  Aleksandra K Wierzbowski; Dean Swedlo; Dave Boyd; Michael Mulvey; Kim A Nichol; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.

Authors:  Aleksandra K Wierzbowski; Dave Boyd; Michael Mulvey; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece.

Authors:  Ioanna N Grivea; Alexia Sourla; Eleni Ntokou; Denise C Chryssanthopoulou; Alexandra G Tsantouli; George A Syrogiannopoulos
Journal:  BMC Infect Dis       Date:  2012-10-11       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.